Adorini, L. (2002). Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. International Immunopharmacology, 2(7), 1017-1028.
doi:http://dx.doi.org/10.1016/S1567-5769(02)00049-8
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., . . . Hawker, G. (2010). 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Arthritis & Rheumatism, 62(9), 2569-2581. doi:10.1002/art.27584
Andjelkovic, Z., Vojinovic, J., Pejnovic, N., Popovic, M., Dujic, A., Mitrovic, D., . . . Stefanovic, D. (1999). Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp Rheumatol, 17(4), 453-456.
Anthony, R. M., Wermeling, F., Karlsson, M. C. I., & Ravetch, J. V. (2008). Identification of a receptor required for the anti-inflammatory activity of IVIG. Proceedings of the National Academy of Sciences, 105(50), 19571-19578. doi:10.1073/pnas.0810163105 Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., . . .
Hunder, G. G. (2005). The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis & Rheumatism, 31, 315–324.
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007). The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins. Annual Review of Immunology, 25(1), 21-50.
doi:doi:10.1146/annurev.immunol.25.022106.141702
Bas, S. (2003). Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology, 42(5), 677-680.
doi:10.1093/rheumatology/keg184
Bax, M., Huizinga, T. W., & Toes, R. E. (2014). The pathogenic potential of autoreactive antibodies in rheumatoid arthritis. Semin Immunopathol, 36(3), 313-325.
doi:10.1007/s00281-014-0429-5
Bohm, S., Schwab, I., Lux, A., & Nimmerjahn, F. (2012). The role of sialic acid as a modulator of the anti-inflammatory activity of IgG. Semin Immunopathol, 34(3), 443-453. doi:10.1007/s00281-012-0308-x
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., . . . Schnitzer, T. J. (2000). Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis. New England Journal of Medicine, 343(21), 1520-1528. doi:doi:10.1056/NEJM200011233432103
Bykerk, V. P., & Massarotti, E. M. (2012). The new ACR/EULAR remission criteria:
rationale for developing new criteria for remission. Rheumatology (Oxford), 51 Suppl 6, vi16-20. doi:10.1093/rheumatology/kes281
Literatur
Collins, E. S., Galligan, M. C., Saldova, R., Adamczyk, B., Abrahams, J. L., Campbell, M. P., . . . Fitzgerald, O. (2013). Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment. Rheumatology (Oxford), 52(9), 1572-1582.
doi:10.1093/rheumatology/ket189
Croce, A., Firuzi, O., Altieri, F., Eufemi, M., Agostino, R., Priori, R., . . . Saso, L. (2007).
Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis.
Journal of Clinical Laboratory Analysis, 21(5), 303-314. doi:10.1002/jcla.20191 Cutolo, M., Villaggio, B., Otsa, K., Aakre, O., Sulli, A., & Seriolo, B. (2005). Altered
circadian rhythms in rheumatoid arthritis patients play a role in the disease's
symptoms. Autoimmunity Reviews, 4(8), 497-502.
doi:http://dx.doi.org/10.1016/j.autrev.2005.04.019
De Graaf, T. W., Van Ommen, E. C., Van der Stelt, M. E., Kerstens, P. J., Boerbooms, A. M.,
& Van Dijk, W. (1994). Effects of low dose methotrexate therapy on the concentration and the glycosylation of alpha 1-acid glycoprotein in the serum of patients with rheumatoid arthritis: a longitudinal study. J Rheumatol, 21(12), 2209-2216.
Doran, M. F., Pond, G. R., Crowson, C. S., O'Fallon, W. M., & Gabriel, S. E. (2002). Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis & Rheumatism, 46(3), 625-631. doi:10.1002/art.509
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., . . . Shaw, T. (2004). Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis. New England Journal of Medicine, 350(25), 2572-2581. doi:doi:10.1056/NEJMoa032534
Ferrara, C., Stuart, F., Sondermann, P., Brünker, P., & Umaña, P. (2006). The Carbohydrate at FcγRIIIa Asn-162: AN ELEMENT REQUIRED FOR HIGH AFFINITY BINDING TO NON-FUCOSYLATED IgG GLYCOFORMS. Journal of Biological Chemistry, 281(8), 5032-5036. doi:10.1074/jbc.M510171200
Fillatreau, S. (2015). Pathogenic functions of B cells in autoimmune diseases: IFN-γ production joins the criminal gang. European Journal of Immunology, 45(4), 966-970.
doi:10.1002/eji.201545544
Gińdzieńska-Sieśkiewicz, E., Radziejewska, I., Domysławska, I., Klimiuk, P. A., Sulik, A., Rojewska, J., . . . Sierakowski, S. (2016). Changes of glycosylation of IgG in rheumatoid arthritis patients treated with methotrexate. Advances in Medical Sciences, 61(2), 193-197. doi:http://dx.doi.org/10.1016/j.advms.2015.12.009
Greenwood, M. C., Doyle, D. V., & Ensor, M. (2001). Does the Stanford Health Assessment Questionnaire have potential as a monitoring tool for subjects with rheumatoid arthritis? Ann Rheum Dis, 60(4), 344-348. doi:10.1136/ard.60.4.344
Harre, U., Georgess, D., Bang, H., Bozec, A., Axmann, R., Ossipova, E., . . . Schett, G.
(2012). Induction of osteoclastogenesis and bone loss by human autoantibodies
Literatur
96 against citrullinated vimentin. The Journal of Clinical Investigation, 122(5), 1791-1802. doi:10.1172/JCI60975
Haseley, S. R., Talaga, P., Kamerling, J. P., & Vliegenthart, J. F. G. (1999). Characterization of the Carbohydrate Binding Specificity and Kinetic Parameters of Lectins by Using Surface Plasmon Resonance. Analytical Biochemistry, 274(2), 203-210.
doi:http://dx.doi.org/10.1006/abio.1999.4277
Hetland, M. L., Ejbjerg, B., Hørslev-Petersen, K., Jacobsen, S., Vestergaard, A., Jurik, A. G., . . . and the, C. s. g. (2009). MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis, 68(3), 384-390.
doi:10.1136/ard.2008.088245
Hettenkofer, H.-J., Schneider, M., & Braun, J. (2003). Rheumatologie: Thieme.
Horn, F. (2012). Biochemie des Menschen: Geord Thieme Verlag Stuttgart New York.
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997). Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States.
Clinical Immunology and Immunopathology, 84(3), 223-243.
doi:http://dx.doi.org/10.1006/clin.1997.4412
Jefferis, R., Lund, J., & Goodall, M. (1995). Recognition sites on human IgG for Fcγ receptors: the role of glycosylation. Immunology Letters, 44(2–3), 111-117.
doi:http://dx.doi.org/10.1016/0165-2478(94)00201-2
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006). Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation. Science, 313(5787), 670-673.
doi:10.1126/science.1129594
Kay, J., & Upchurch, K. S. (2012). ACR/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxford), 51 Suppl 6, vi5-9. doi:10.1093/rheumatology/kes279 Kirwan, J. R., Bijlsma, J. W., Boers, M., & Shea, B. J. (2007). Effects of glucocorticoids on
radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev(1), CD006356. doi:10.1002/14651858.CD006356
Klareskog, L., Padyukov, L., & Alfredsson, L. (2007). Smoking as a trigger for inflammatory rheumatic diseases. Current Opinion in Rheumatology, 19(1), 49-54.
doi:10.1097/BOR.0b013e32801127c8
Klareskog, L., Stolt, P., Lundberg, K., Källberg, H., Bengtsson, C., Grunewald, J., . . . Alfredsson, L. (2006). A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination. Arthritis & Rheumatism, 54(1), 38-46.
doi:10.1002/art.21575
Kramer, H. R., & Giles, J. T. (2011). Cardiovascular disease risk in rheumatoid arthritis:
Progress, debate, and opportunity. Arthritis Care & Research, 63(4), 484-499.
doi:10.1002/acr.20386
Literatur
97 Kranz, C., Denecke, J., Lehrman, M. A., Ray, S., Kienz, P., Kreissel, G., . . . Marquardt, T.
(2001). A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If). Journal of Clinical Investigation, 108(11), 1613-1619.
Kroot, E.-J. J. A., De Jong, B. A. W., Van Leeuwen, M. A., Swinkels, H., Van Den Hoogen, F. H. J., Van 't Hof, M., . . . Van Riel, P. L. C. M. (2000). The prognostic value of anti–cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis & Rheumatism, 43(8), 1831-1835. doi:10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6
Lappin, D. F., Apatzidou, D., Quirke, A. M., Oliver-Bell, J., Butcher, J. P., Kinane, D. F., . . . Culshaw, S. (2013). Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres. J Clin Periodontol, 40(10), 907-915. doi:10.1111/jcpe.12138
Li, P., Li, M., Lindberg, M. R., Kennett, M. J., Xiong, N., & Wang, Y. (2010). PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps.
J Exp Med, 207(9), 1853-1862. doi:10.1084/jem.20100239
Lineker, S., Badley, E., Charles, C., Hart, L., & Streiner, D. (1999). Defining morning stiffness in rheumatoid arthritis. J Rheumatol, 26(5), 1052-1057.
Lux, A., & Nimmerjahn, F. (2011). Impact of differential glycosylation on IgG activity. Adv Exp Med Biol, 780, 113-124. doi:10.1007/978-1-4419-5632-3_10
Machold, K. P., Stamm, T. A., Eberl, G. J. M., Nell, V. K. P., Dunky, A., Uffmann, M., &
Smolen, J. S. (2002). Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease. J Rheumatol, 29(11), 2278-2287.
Makrygiannakis, D., Hermansson, M., Ulfgren, A. K., Nicholas, A. P., Zendman, A. J. W., Eklund, A., . . . Catrina, A. I. (2008). Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis, 67(10), 1488-1492. doi:10.1136/ard.2007.075192
Mankarious, S., Lee, M., Fischer, S., Pyun, K. H., Ochs, H. D., Oxelius, V. A., & Wedgwood, R. J. (1988). The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin. The Journal of laboratory and clinical medicine, 112(5), 634-640.
Mastrangelo, A., Colasanti, T., Barbati, C., Pecani, A., Sabatinelli, D., Pendolino, M., . . . Alessandri, C. (2015). The Role of Posttranslational Protein Modifications in Rheumatological Diseases: Focus on Rheumatoid Arthritis. Journal of Immunology Research, 2015, 712490. doi:10.1155/2015/712490
McInnes, I. B., & O'Dell, J. R. (2010). State-of-the-art: rheumatoid arthritis. Ann Rheum Dis, 69(11), 1898-1906. doi:10.1136/ard.2010.134684
Merlino, L. A., Curtis, J., Mikuls, T. R., Cerhan, J. R., Criswell, L. A., & Saag, K. G. (2004).
Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women's Health Study. Arthritis & Rheumatism, 50(1), 72-77.
doi:10.1002/art.11434
Literatur
98 Negi, V.-S., Elluru, S., SibÉRil, S., Graff-Dubois, S., Mouthon, L. U. C., Kazatchkine, M. D., . . . Kaveri, S. V. (2007). Intravenous Immunoglobulin: An Update on the Clinical Use and Mechanisms of Action. Journal of Clinical Immunology, 27(3), 233-245.
doi:10.1007/s10875-007-9088-9
Nimmerjahn, F., & Ravetch, J. V. (2005). Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding. Science
, 310, 1510-1512
Nimmerjahn, F., & Ravetch, J. V. (2008). Anti-Inflammatory Actions of Intravenous Immunoglobulin. Annual Review of Immunology, 26(1), 513-533.
doi:doi:10.1146/annurev.immunol.26.021607.090232
Nishimura, K., Sugiyama, D., Kogata, Y., Tsuji, G., Nakazawa, T., Kawano, S., . . . Kumagai, S. (2007). Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis. Annals of Internal Medicine, 146(11), 797-808. doi:10.7326/0003-4819-146-11-200706050-00008 Niwa, R., Natsume, A., Uehara, A., Wakitani, M., Iida, S., Uchida, K., . . . Shitara, K. (2005).
IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides. Journal of Immunological Methods, 306(1–2), 151-160. doi:http://dx.doi.org/10.1016/j.jim.2005.08.009
O'Dell, J. R. (2004). Therapeutic Strategies for Rheumatoid Arthritis. New England Journal of Medicine, 350(25), 2591-2602. doi:doi:10.1056/NEJMra040226
O'Dell, J. R., Haire, C. E., Erikson, N., Drymalski, W., Palmer, W., Eckhoff, J., . . . Moore, G.
F. (1996). Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications. The New England Journal of Medicine, 334, 1287-1291. doi: 10.1056/NEJM199605163342002 Ohtsubo, K., & Marth, J. D. (2006). Glycosylation in Cellular Mechanisms of Health and
Disease. Cell, 126(5), 855-867. doi:http://dx.doi.org/10.1016/j.cell.2006.08.019
Orczyk-Pawiłowicz, M., Augustyniak, D., Hirnle, L., & Kątnik-Prastowska, I. (2012). Degree of sialylation and fucosylation of plasma and amniotic immunoglobulin G changes progressively during normal pregnancy. Prenatal Diagnosis, 32(5), 432-439.
doi:10.1002/pd.3832
Parekh, R., Isenberg, D., Ansell, B., Roitt, I., Dwek, R., & Rademacher, T. (1988).
Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. The Lancet, 331(8592), 966-969. doi:http://dx.doi.org/10.1016/S0140-6736(88)91781-3
Pasek, M., Duk, M., Podbielska, M., Sokolik, R., Szechiński, J., Lisowska, E., &
Krotkiewski, H. (2006). Galactosylation of IgG from rheumatoid arthritis (RA) patients – changes during therapy. Glycoconj J, 23(7-8), 463-471.
doi:10.1007/s10719-006-5409-0
Perry, E., Kelly, C., Eggleton, P., De Soyza, A., & Hutchinson, D. (2014). The lung in ACPA-positive rheumatoid arthritis: an initiating site of injury? Rheumatology, 53(11), 1940-1950. doi:10.1093/rheumatology/keu195
Literatur
99 Pötschke-Langer, M., Mons M. A., U., Schaller, K., Stein, S., Kahnert, S., Schneider, N. K., . . . Mersmann, H. (2009). Tabakatlas Deutschland 2009 (D. Krebsforschungszentrum Ed.): Steinkopf-Verlag Heidelberg.
Pratesi, F., Dioni, I., Tommasi, C., Alcaro, M. C., Paolini, I., Barbetti, F., . . . Migliorini, P.
(2014). Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. Ann Rheum Dis, 73(7), 1414-1422.
doi:10.1136/annrheumdis-2012-202765
Rademacher, T. W., Williams, P., & Dwek, R. A. (1994). Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proceedings of the National Academy of Sciences, 91(13), 6123-6127.
Rantapää-Dahlqvist, S., de Jong, B. A. W., Berglin, E., Hallmans, G., Wadell, G., Stenlund, H., . . . van Venrooij, W. J. (2003). Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis &
Rheumatism, 48(10), 2741-2749. doi:10.1002/art.11223
Rao, J. K., & Mihaliak, K. (1999). Use of complementary therapies for arthritis among patients of rheumatologists. Annals of Internal Medicine, 131(6), 409.
Raza, K., Falciani, F., Curnow, S. J., Ross, E. J., Lee, C. Y., Akbar, A. N., . . . Salmon, M.
(2005). Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther, 7(4), R784-795. doi:10.1186/ar1733
Ruiz-Esquide, V., Gómara, M., Peinado, V., Gómez Puerta, J., Barberá, J., Cañete, J. d. D., . . . Sanmartí, R. (2012). Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease? Clinical Rheumatology, 31(7), 1047-1050. doi:10.1007/s10067-012-1971-y
Saraux, A., Berthelot, J. M., Gérard, C., Le Henaff, C., Mary, J. Y., Thorel, J. B., . . . Youinou, P. (2002). Value of laboratory tests in early prediction of rheumatoid arthritis. Arthritis Care & Research, 47(2), 155-165. doi:10.1002/art.10241
Satoh, M., Iida, S., & Shitara, K. (2006). Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies. Expert Opinion on Biological Therapy, 6(11), 1161-1173. doi:doi:10.1517/14712598.6.11.1161
Schartl, M., Gessler, M., & Eckardstein, A. v. (2009). Biochemie des Menschen: Urban &
Fischer.
Scherer, H. U., van der Woude, D., Ioan-Facsinay, A., el Bannoudi, H., Trouw, L. A., Wang, J., . . . Toes, R. E. M. (2010). Glycan profiling of anti–citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis & Rheumatism, 62(6), 1620-1629. doi:10.1002/art.27414
Schett, G., & David, J. P. (2010). The multiple faces of autoimmune-mediated bone loss. Nat Rev Endocrinol, 6(12), 698-706. doi:10.1038/nrendo.2010.190
Schett, G., & Gravallese, E. (2012). Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol, 8(11), 656-664.
Literatur
100 Shi, J., Knevel, R., Suwannalai, P., van der Linden, M. P., Janssen, G. M. C., van Veelen, P.
A., . . . Trouw, L. A. (2011). Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.
Proceedings of the National Academy of Sciences, 108(42), 17372-17377.
doi:10.1073/pnas.1114465108
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., . . . Shitara, K. (2003). The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity.
Journal of Biological Chemistry, 278(5), 3466-3473. doi:10.1074/jbc.M210665200 Smolen, J. S., Landewé, R., Breedveld, F. C., Dougados, M., Emery, P., Gaujoux-Viala, C., . .
. van der Heijde, D. (2010). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis, 69(6), 964-975. doi:10.1136/ard.2009.126532
Sokka, T., & Pincus, T. (2009). Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States. J Rheumatol, 36(7), 1387-1390. doi:10.3899/jrheum.080770
Solomon, S. D., Wittes, J., Finn, P. V., Fowler, R., Viner, J., Bertagnolli, M. M., . . . for the Cross Trial Safety Assessment, G. (2008). Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials: The Cross Trial Safety Analysis. Circulation, 117(16), 2104-2113. doi:10.1161/circulationaha.108.764530
Song, I.-H., & Sieper, J. (2008). Rheumatoide Arthritis Harrisons Innere Medizin (17 ed., Vol. 2, pp. 2569-2580): M. Dietel, N. Suttorp, M. Zeitz.
Stanford, S. M., Svensson, M. N., Sacchetti, C., Pilo, C. A., Wu, D. J., Kiosses, W. B., . . . Bottini, N. (2015). "Receptor protein tyrosine phosphatase alpha enhances rheumatoid synovial fibroblast signaling and promotes arthritis in mice". Arthritis Rheumatol.
doi:10.1002/art.39442
Stastny, P. (1978). Association of the B-Cell Alloantigen DRw4 with Rheumatoid Arthritis.
New England Journal of Medicine, 298(16), 869-871.
doi:10.1056/NEJM197804202981602
Suzuki, A., Yamada, R., Chang, X., Tokuhiro, S., Sawada, T., Suzuki, M., . . . Yamamoto, K.
(2003). Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet,
34(4), 395-402.
doi:http://www.nature.com/ng/journal/v34/n4/suppinfo/ng1206_S1.html
Symmons, D. P. M. (2002). Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Practice & Research Clinical Rheumatology, 16(5), 707-722. doi:http://dx.doi.org/10.1053/berh.2002.0257
Tackenberg, B., Jelčić, I., Baerenwaldt, A., Oertel, W. H., Sommer, N., Nimmerjahn, F., &
Lünemann, J. D. (2009). Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy. Proceedings of the National Academy of Sciences, 106(12), 4788-4792. doi:10.1073/pnas.0807319106
Literatur
101 Takai, T. (2002). Roles of Fc receptors in autoimmunity. Nat Rev Immunol, 2(8), 580-592.
Thorens, B., & Vassalli, P. (1986). Chloroquine and ammonium chloride prevent terminal glycosylation of immunoglobulins in plasma cells without affecting secretion. Nature, 321(6070), 618-620. doi:10.1038/321618a0
Turesson, C., Jacobsson, L., & Bergström, U. (1999). Extra-articular rheumatoid arthritis:
prevalence and mortality. Rheumatology, 38(7), 668-674.
doi:10.1093/rheumatology/38.7.668
Turesson, C., Jacobsson, L. T. H., Sturfelt, G., Matteson, E. L., Mathsson, L., & Rönnelid, J.
(2007). Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis, 66(1), 59-64. doi:10.1136/ard.2006.054445
van de Geijn, F. E., Wuhrer, M., Selman, M. H. J., Willemsen, S. P., de Man, Y. A., Deelder, A. M., . . . Dolhain, R. J. E. M. (2009). Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Res Ther, 11(6), R193-R193. doi:10.1186/ar2892
van der Heijde, D. M. F. M. (1995). Joint Erosions and Patients with Early Rheumatoid
Arthritis. Rheumatology, XXXIV(suppl 2), 74-78.
doi:10.1093/rheumatology/XXXIV.suppl_2.74
van der Woude, D., Rantapää-Dahlqvist, S., Ioan-Facsinay, A., Onnekink, C., Schwarte, C.
M., Verpoort, K. N., . . . Pruijn, G. J. M. (2010). Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis.
doi:10.1136/ard.2009.124537
van der Woude, D., Syversen, S. W., van der Voort, E. I. H., Verpoort, K. N., Goll, G. L., van der Linden, M. P. M., . . . Toes, R. E. M. (2010). The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis. Ann Rheum Dis.
doi:10.1136/ard.2009.116384
Varadi, C., Hollo, Z., Poliska, S., Nagy, L., Szekanecz, Z., Vancsa, A., . . . Guttman, A.
(2015). Combination of IgG N-glycomics and Corresponding Transcriptomics Data to Identify anti-TNFalpha Treatment Responders in Inflammatory Diseases.
Electrophoresis. doi:10.1002/elps.201400575
Verpoort, K. N., Jol-van der Zijde, C. M., Papendrecht-van der Voort, E. A. M., Ioan-Facsinay, A., Drijfhout, J. W., van Tol, M. J. D., . . . Toes, R. E. M. (2006). Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis &
Rheumatism, 54(12), 3799-3808. doi:10.1002/art.22279
Visser, H. (2005). Early diagnosis of rheumatoid arthritis. Best Practice & Research Clinical Rheumatology, 19(1), 55-72. doi:http://dx.doi.org/10.1016/j.berh.2004.08.005
Visser, H., le Cessie, S., Vos, K., Breedveld, F. C., & Hazes, J. M. W. (2002). How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive) arthritis. Arthritis & Rheumatism, 46(2), 357-365. doi:10.1002/art.10117
Literatur
102 Wang, T. J., Pencina, M. J., Booth, S. L., Jacques, P. F., Ingelsson, E., Lanier, K., . . . Vasan, R. S. (2008). Vitamin D Deficiency and Risk of Cardiovascular Disease. Circulation, 117(4), 503-511. doi:10.1161/circulationaha.107.706127
Whiting, P. F., Smidt, N., Sterne, J. A. C., Harbord, R., Burton, A., Burke, M., . . . Dieppe, P.
(2010). Systematic Review: Accuracy of Anti–Citrullinated Peptide Antibodies for Diagnosing Rheumatoid Arthritis. Annals of Internal Medicine, 152(7), 456-464.
doi:10.7326/0003-4819-152-7-201004060-00010
Anhang
103